Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × veliparib × Clear all

NCT01540565 2019-07-23

Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

52 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms